Savas Research
At Savas Research, we are resolved to advancing medicine by conducting superior phase 1 to phase 4 clinical research trials in pain management and neuroscience.
Who We Are
Our accomplished team of physicians and research specialists have over 50 years of combined experience and are endlessly devoted to producing superior and quality clinical research. View our work.
Our physicians and staff are dedicated to advancing the field of medicine by participating in cutting edge clinical trials. All our physicians have the experience needed to provide quality research data.
*We have a strong team of double board certified physicians at the Principal Investigator and/or the Sub-Investigator level.
Pain Studies
Device Trials
Stem Cell Research
OUR SERVICES
Our principal and sub investigators are physicians who are fellowship-trained MDs, double-board certified in Pain Medicine and Anesthesiology.
PHASE 1-4 CLINICAL TRIALS
We offer Phase I-IV clinical trials providing all pieces of critical information about the effect of a new drug on humans which is necessary for complete development of a drug/therapy. Once the initial Phase I/II trials are complete, drug development may progress into larger clinical studies that continue to test the safety of the new drug and how well it works in treating a particular disorder.
DEVICE & MEDICATION STUDIES
Our investigational device studies observe medical devices as the subject of our clinical studies designed to evaluate the effectiveness and/or safety of the device.
PROOF OF CONCEPT STUDY
A proof-of-concept study is conducted to provide the first evidence that a candidate drug might be effective for a disease. At all stages of clinical development, the criteria for continuing to investigate the candidate drug include safety, tolerability, pharmacokinetics, duration of action, efficacy, patient acceptability, and commercial viability at the planned time of launch.
EXPERIMENTAL PAIN STUDIES
Initial efforts focused on developing reliable methods to quantify pain. With aid of these methods, early research successfully addressed longstanding questions of opioid pharmacology such as tolerance, mode and site of action, and drug-related development of hyperalgesia.
In addition to a sustained interest in opioid pharmacology, multiple methods were implemented to evaluate efficacy and potential clinical utility of novel pain therapeutics and interventions. Today’s studies take advantage of proteomic, genomic, electro-physiological and imaging techniques to delineate new therapeutic pathways, guide clinical development strategies and advance pain therapy.
